| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| September 29th, 2005 | 27 | Yes |
Popular Name: 4-(4-(4-Fluorophenyl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine 4-(4-(4-Fluorophenyl)-2-(4-(meth…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 152121-44-3; 152121-47-6 , 152121-47-6 , 152121-47-6; 869185-85-3 , [152121-47-6]
4-(4'-Fluorophenyl)-2-(4'-methylsulphinylphenyl)-5-(4'-pyridyl)imidazole
4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazol
Pyridine, 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.10 | 8.8 | -21.46 | 1 | 4 | 0 | 59 | 377.444 | 4 | ↓ |
| Lo Low (pH 4.5-6) | 3.10 | 9.25 | -46.75 | 2 | 4 | 1 | 60 | 378.452 | 4 | ↓ |
| Lo Low (pH 4.5-6) | 3.10 | 9.24 | -46.38 | 2 | 4 | 1 | 60 | 378.452 | 4 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Indications | protein kinase inhibitor | KeyOrganics Bioactives |
| Notes | Selective inhibitor of p38 MAP kinase. Inhibitor of p40 kinase . | Apollo Scientific Bioactives |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| ACV1B-1-E | Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.29 | Binding ≤ 10μM |
| ADCK4-1-E | Uncharacterized AarF Domain-containing Protein Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.29 | Binding ≤ 10μM |
| BRAF-1-E | Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic | Eukaryotes | 710 | 0.32 | Binding ≤ 10μM |
| CTRO-1-E | Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 420 | 0.33 | Binding ≤ 10μM |
| DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.31 | Binding ≤ 10μM |
| DDR2-1-E | Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.27 | Binding ≤ 10μM |
| EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 710 | 0.32 | Binding ≤ 10μM |
| EPHA6-1-E | Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| EPHB2-1-E | Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7800 | 0.26 | Binding ≤ 10μM |
| FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4400 | 0.28 | Binding ≤ 10μM |
| GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 39 | 0.38 | Binding ≤ 10μM |
| GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
| KC1AL-1-E | Casein Kinase I Isoform Alpha-like (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.30 | Binding ≤ 10μM |
| KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 37 | 0.39 | Binding ≤ 10μM |
| KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 220 | 0.35 | Binding ≤ 10μM |
| KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 320 | 0.34 | Binding ≤ 10μM |
| KS6A6-1-E | Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 250 | 0.34 | Binding ≤ 10μM |
| LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 7800 | 0.26 | Binding ≤ 10μM |
| M4K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.28 | Binding ≤ 10μM |
| MK08-1-E | Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1200 | 0.31 | Binding ≤ 10μM |
| MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 95 | 0.36 | Binding ≤ 10μM |
| MK10-2-E | C-Jun N-terminal Kinase 3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 90 | 0.37 | Binding ≤ 10μM |
| MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 78 | 0.37 | Binding ≤ 10μM |
| MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 56 | 0.38 | Binding ≤ 10μM |
| MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 56 | 0.38 | Binding ≤ 10μM |
| MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 72 | 0.37 | Binding ≤ 10μM |
| MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4400 | 0.28 | Binding ≤ 10μM |
| MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9600 | 0.26 | Binding ≤ 10μM |
| MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6200 | 0.27 | Binding ≤ 10μM |
| MRCKB-1-E | Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2700 | 0.29 | Binding ≤ 10μM |
| MRCKG-1-E | Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.33 | Binding ≤ 10μM |
| NLK-1-E | Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 25 | 0.39 | Binding ≤ 10μM |
| PGH1-1-E | Cyclooxygenase-1 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 2000 | 0.30 | Binding ≤ 10μM |
| PTK6-1-E | Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9000 | 0.26 | Binding ≤ 10μM |
| Q5SC61-1-E | Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.36 | Binding ≤ 10μM |
| RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 980 | 0.31 | Binding ≤ 10μM |
| RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 24 | 0.40 | Binding ≤ 10μM |
| SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4600 | 0.28 | Binding ≤ 10μM |
| SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5300 | 0.27 | Binding ≤ 10μM |
| ST32B-1-E | Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.29 | Binding ≤ 10μM |
| STK36-1-E | Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 860 | 0.31 | Binding ≤ 10μM |
| TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7100 | 0.27 | Binding ≤ 10μM |
| TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1800 | 0.30 | Binding ≤ 10μM |
| TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.28 | Binding ≤ 10μM |
| TNIK-1-E | TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 820 | 0.32 | Binding ≤ 10μM |
| TTK-1-E | Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2500 | 0.29 | Binding ≤ 10μM |
| TXK-1-E | Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.28 | Binding ≤ 10μM |
| LOX5-1-E | Arachidonate 5-lipoxygenase (cluster #1 Of 7), Eukaryotic | Eukaryotes | 80 | 0.37 | Functional ≤ 10μM |
| MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
| MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
| MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
| MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 940 | 0.31 | Functional ≤ 10μM |
| TNFA-1-E | TNF-alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 70 | 0.37 | Functional ≤ 10μM |
| Z100081-1-O | PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other | Other | 80 | 0.37 | Functional ≤ 10μM |
| Z102116-1-O | Toxoplasma Gondii RH (cluster #1 Of 2), Other | Other | 8500 | 0.26 | Functional ≤ 10μM |
| Z50472-1-O | Toxoplasma Gondii (cluster #1 Of 4), Other | Other | 2500 | 0.29 | Functional ≤ 10μM |
| Z50587-1-O | Homo Sapiens (cluster #1 Of 9), Other | Other | 940 | 0.31 | Functional ≤ 10μM |
| Z80523-1-O | SW1353 (cluster #1 Of 2), Other | Other | 50 | 0.38 | Functional ≤ 10μM |
| Z80548-1-O | THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other | Other | 72 | 0.37 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 130 | 0.36 | Binding ≤ 1μM |
| MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 290 | 0.34 | Binding ≤ 1μM |
| KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 120 | 0.36 | Binding ≤ 1μM |
| KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 100 | 0.36 | Binding ≤ 1μM |
| CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 420 | 0.33 | Binding ≤ 1μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 340 | 0.34 | Binding ≤ 1μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 1000 | 0.31 | Binding ≤ 1μM |
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 10 | 0.41 | Binding ≤ 1μM |
| MK14_MOUSE | P47811 | MAP Kinase P38 Alpha, Mouse | 136 | 0.36 | Binding ≤ 1μM |
| MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 10 | 0.41 | Binding ≤ 1μM |
| MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 10 | 0.41 | Binding ≤ 1μM |
| MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 10 | 0.41 | Binding ≤ 1μM |
| Q5SC61_TOXGO | Q5SC61 | Mitogen-activated Protein Kinase 1, Toxgo | 100 | 0.36 | Binding ≤ 1μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 320 | 0.34 | Binding ≤ 1μM |
| KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 250 | 0.34 | Binding ≤ 1μM |
| NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 25 | 0.39 | Binding ≤ 1μM |
| STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 860 | 0.31 | Binding ≤ 1μM |
| BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 530 | 0.33 | Binding ≤ 1μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 135 | 0.36 | Binding ≤ 1μM |
| MRCKG_HUMAN | Q6DT37 | Serine/threonine-protein Kinase MRCK Gamma, Human | 400 | 0.33 | Binding ≤ 1μM |
| RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 330 | 0.34 | Binding ≤ 1μM |
| RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 16 | 0.40 | Binding ≤ 1μM |
| TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 820 | 0.32 | Binding ≤ 1μM |
| ACV1B_HUMAN | P36896 | Activin Receptor Type-1B, Human | 3000 | 0.29 | Binding ≤ 10μM |
| MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 1100 | 0.31 | Binding ≤ 10μM |
| MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 130 | 0.36 | Binding ≤ 10μM |
| MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 290 | 0.34 | Binding ≤ 10μM |
| KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 120 | 0.36 | Binding ≤ 10μM |
| KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 100 | 0.36 | Binding ≤ 10μM |
| KC1AL_HUMAN | Q8N752 | Casein Kinase I Isoform Alpha-like, Human | 1700 | 0.30 | Binding ≤ 10μM |
| CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 420 | 0.33 | Binding ≤ 10μM |
| PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 2000 | 0.30 | Binding ≤ 10μM |
| DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 5000 | 0.27 | Binding ≤ 10μM |
| MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 9600 | 0.26 | Binding ≤ 10μM |
| TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 2500 | 0.29 | Binding ≤ 10μM |
| EPHA6_HUMAN | Q9UF33 | Ephrin Type-A Receptor 6, Human | 1200 | 0.31 | Binding ≤ 10μM |
| EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 6800 | 0.27 | Binding ≤ 10μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1300 | 0.31 | Binding ≤ 10μM |
| DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 1000 | 0.31 | Binding ≤ 10μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1700 | 0.30 | Binding ≤ 10μM |
| MK14_MOUSE | P47811 | MAP Kinase P38 Alpha, Mouse | 136 | 0.36 | Binding ≤ 10μM |
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 10 | 0.41 | Binding ≤ 10μM |
| MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 10 | 0.41 | Binding ≤ 10μM |
| MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 10 | 0.41 | Binding ≤ 10μM |
| MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 10 | 0.41 | Binding ≤ 10μM |
| Q5SC61_TOXGO | Q5SC61 | Mitogen-activated Protein Kinase 1, Toxgo | 100 | 0.36 | Binding ≤ 10μM |
| M4K4_HUMAN | O95819 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4, Human | 3700 | 0.28 | Binding ≤ 10μM |
| MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 4400 | 0.28 | Binding ≤ 10μM |
| KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 320 | 0.34 | Binding ≤ 10μM |
| KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 250 | 0.34 | Binding ≤ 10μM |
| NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 25 | 0.39 | Binding ≤ 10μM |
| SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 3700 | 0.28 | Binding ≤ 10μM |
| ST32B_HUMAN | Q9NY57 | Serine/threonine-protein Kinase 32B, Human | 2100 | 0.29 | Binding ≤ 10μM |
| STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 1300 | 0.31 | Binding ≤ 10μM |
| BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 530 | 0.33 | Binding ≤ 10μM |
| GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 135 | 0.36 | Binding ≤ 10μM |
| MRCKB_HUMAN | Q9Y5S2 | Serine/threonine-protein Kinase MRCK Beta, Human | 2700 | 0.29 | Binding ≤ 10μM |
| MRCKG_HUMAN | Q6DT37 | Serine/threonine-protein Kinase MRCK Gamma, Human | 400 | 0.33 | Binding ≤ 10μM |
| MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 6200 | 0.27 | Binding ≤ 10μM |
| RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 2000 | 0.30 | Binding ≤ 10μM |
| RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 16 | 0.40 | Binding ≤ 10μM |
| TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 3500 | 0.28 | Binding ≤ 10μM |
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 6000 | 0.27 | Binding ≤ 10μM |
| TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 1800 | 0.30 | Binding ≤ 10μM |
| TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 1500 | 0.30 | Binding ≤ 10μM |
| PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 3900 | 0.28 | Binding ≤ 10μM |
| FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 1800 | 0.30 | Binding ≤ 10μM |
| LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 2800 | 0.29 | Binding ≤ 10μM |
| SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 5000 | 0.27 | Binding ≤ 10μM |
| TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 4500 | 0.28 | Binding ≤ 10μM |
| ADCK4_HUMAN | Q96D53 | Uncharacterized AarF Domain-containing Protein Kinase 4, Human | 3100 | 0.29 | Binding ≤ 10μM |
| LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 80 | 0.37 | Functional ≤ 10μM |
| Z50587 | Z50587 | Homo Sapiens | 2000 | 0.30 | Functional ≤ 10μM |
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 1000 | 0.31 | Functional ≤ 10μM |
| MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 1000 | 0.31 | Functional ≤ 10μM |
| MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 1000 | 0.31 | Functional ≤ 10μM |
| MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 1000 | 0.31 | Functional ≤ 10μM |
| Z100081 | Z100081 | PBMC (Peripheral Blood Mononuclear Cells) | 160 | 0.35 | Functional ≤ 10μM |
| Z80523 | Z80523 | SW1353 | 50 | 0.38 | Functional ≤ 10μM |
| Z80548 | Z80548 | THP-1 (Acute Monocytic Leukemia Cells) | 16 | 0.40 | Functional ≤ 10μM |
| TNFA_HUMAN | P01375 | TNF-alpha, Human | 70 | 0.37 | Functional ≤ 10μM |
| Z50472 | Z50472 | Toxoplasma Gondii | 2500 | 0.29 | Functional ≤ 10μM |
| Z102116 | Z102116 | Toxoplasma Gondii RH | 8500 | 0.26 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| activated TAK1 mediates p38 MAPK activation | |
| Activation of BIM and translocation to mitochondria | |
| Activation of BMF and translocation to mitochondria | |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
| Activation of the AP-1 family of transcription factors | |
| ADP signalling through P2Y purinoceptor 1 | |
| AKT phosphorylates targets in the cytosol | |
| APC truncation mutants have impaired AXIN binding | |
| ARMS-mediated activation | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| Ca2+ pathway | |
| CD28 co-stimulation | |
| CD28 dependent PI3K/Akt signaling | |
| CD28 dependent Vav1 pathway | |
| CDO in myogenesis | |
| Circadian Clock | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| COX reactions | |
| CREB phosphorylation | |
| CREB phosphorylation through the activation of Ras | |
| CRMPs in Sema3A signaling | |
| CTLA4 inhibitory signaling | |
| DAP12 signaling | |
| Degradation of beta-catenin by the destruction complex | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| Downregulation of TGF-beta receptor signaling | |
| Downstream TCR signaling | |
| DSCAM interactions | |
| EGFR downregulation | |
| EGFR interacts with phospholipase C-gamma | |
| EGFR Transactivation by Gastrin | |
| EPH-ephrin mediated repulsion of cells | |
| EPH-Ephrin signaling | |
| EPHA-mediated growth cone collapse | |
| EPHB-mediated forward signaling | |
| Ephrin signaling | |
| ERK/MAPK targets | |
| ERK2 activation | |
| FCERI mediated Ca+2 mobilization | |
| FCERI mediated MAPK activation | |
| Frs2-mediated activation | |
| GAB1 signalosome | |
| Gastrin-CREB signalling pathway via PKC and MAPK | |
| Generation of second messenger molecules | |
| Golgi Associated Vesicle Biogenesis | |
| GP1b-IX-V activation signalling | |
| GPVI-mediated activation cascade | |
| GRB2 events in EGFR signaling | |
| GRB2 events in ERBB2 signaling | |
| Interleukin-1 signaling | |
| Interleukin-2 signaling | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| KSRP destabilizes mRNA | |
| L1CAM interactions | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MEK activation | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| Nef and signal transduction | |
| Nef Mediated CD4 Down-regulation | |
| NOD1/2 Signaling Pathway | |
| Non-integrin membrane-ECM interactions | |
| NRAGE signals death through JNK | |
| NRIF signals cell death from the nucleus | |
| Oxidative Stress Induced Senescence | |
| p38MAPK events | |
| p75NTR recruits signalling complexes | |
| PD-1 signaling | |
| PECAM1 interactions | |
| Phosphorylation of CD3 and TCR zeta chains | |
| PI3K events in ERBB2 signaling | |
| PIP3 activates AKT signaling | |
| Platelet sensitization by LDL | |
| PLCG1 events in ERBB2 signaling | |
| RAF activation | |
| RAF phosphorylates MEK | |
| Rap1 signalling | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recycling pathway of L1 | |
| Regulation of HSF1-mediated heat shock response | |
| Regulation of KIT signaling | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of signaling by NODAL | |
| RSK activation | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| Senescence-Associated Secretory Phenotype (SASP) | |
| SHC1 events in EGFR signaling | |
| SHC1 events in ERBB2 signaling | |
| Signal transduction by L1 | |
| Signaling by Activin | |
| Signaling by constitutively active EGFR | |
| Signaling by EGFR | |
| Signaling by ERBB2 | |
| Signaling by ERBB4 | |
| Signaling by FGFR | |
| Signaling by NODAL | |
| Signaling by SCF-KIT | |
| Signalling to p38 via RIT and RIN | |
| SMAD2/3 MH2 Domain Mutants in Cancer | |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
| Spry regulation of FGF signaling | |
| Stimuli-sensing channels | |
| Synthesis of 5-eicosatetraenoic acids | |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | |
| Synthesis of Lipoxins (LX) | |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
| TGF-beta receptor signaling activates SMADs | |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
| TGFBR1 KD Mutants in Cancer | |
| TGFBR1 LBD Mutants in Cancer | |
| TGFBR2 Kinase Domain Mutants in Cancer | |
| TGFBR2 MSI Frameshift Mutants in Cancer | |
| TNF signaling | |
| Transcriptional regulation of white adipocyte differentiation | |
| Translocation of ZAP-70 to Immunological synapse | |
| truncations of AMER1 destabilize the destruction complex | |
| Uptake and function of anthrax toxins | |
| VEGFA-VEGFR2 Pathway | |
| WNT mediated activation of DVL |
No pre-computed analogs available. Try a structural similarity search.